levofloxacin-based triple therapy
Showing 1 - 25 of >10,000
Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to Trial in Karachi (Sequential Regimen:
Completed
- Helicobacter Pylori Infection
- Helicobacter Pylori Infection, Susceptibility to
- Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID
- Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID
-
Karachi, Sindh, PakistanJamal Noor Hospital, Karachi
May 8, 2023
Helicobacter Pylori Infection, Helicobacter Pylori Eradication Trial in Dhaka (group A : Amoxicillin Esomeprazole HDDT, group-B
Recruiting
- Helicobacter Pylori Infection
- Helicobacter Pylori Eradication
- group A : Amoxicillin Esomeprazole HDDT
- group-B : Levofloxacin triple therapy
-
Dhaka, BangladeshBangabandhu sheikh mujib medical university
Oct 12, 2023
Helicobacter Pylori Infection Trial in Damascus (sequential, Levofloxacin 500Mg Oral Tablet)
Not yet recruiting
- Helicobacter Pylori Infection
- sequential
- Levofloxacin 500Mg Oral Tablet
-
Damascus, Syrian Arab RepublicGeneral Assembly of Damascus Hospital
Sep 27, 2023
H.Pylori Infection Trial in Liaocheng (clarithromycin-containing triple therapy, bismuth quadruple therapy, a PPI-amoxicillin
Recruiting
- Helicobacter Pylori Infection
-
Liaocheng, Shandong, ChinaLiaocheng people's hospital
Dec 15, 2022
Helicobacter Pylori Infection Trial in Zagazig (Black Seed Oil Cap/Tab, Vonoprazan, Amoxicillin and Clarithromycin)
Not yet recruiting
- Helicobacter Pylori Infection
- Black Seed Oil Cap/Tab
- Vonoprazan, Amoxicillin and Clarithromycin
-
Zagazig, EgyptGIT department zagazig university hospital
Jul 14, 2023
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Helicobacter Pylori Infection Trial in Alexandria (standard Clarithromycin triple therapy, Vonoprazan triple therapy, Vonoprazan
Recruiting
- Helicobacter Pylori Infection
- standard Clarithromycin triple therapy
- +2 more
-
Alexandria, EgyptAlexandria University outpatient clinics
Nov 7, 2022
Helicobacter Pylori Trial in New Taipei City (Vonoprazan-based triple therapy, Extended sequential therapy)
Recruiting
- Helicobacter Pylori
- Vonoprazan-based triple therapy
- Extended sequential therapy
-
New Taipei City, TaiwanFu Jen Catholic University Hospital
May 8, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Dermatomyositis, Adult Type, Interstitial Lung Disease Trial in Nanjing (triple therapy, dual-therapy)
Recruiting
- Dermatomyositis, Adult Type
- Interstitial Lung Disease
- triple therapy
- dual-therapy
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
May 20, 2022
HIV Reservoir, Inflammation and Microbiota Footprint of PLWH
Recruiting
- HIV Infections
- Stool sampling
- Blood plasma collection
-
Marseille, FranceHôpital Européen Marseille
Jul 26, 2022
TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- A1:SG with SHR3680
- +7 more
- (no location specified)
Jun 23, 2023
HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
-
Shanghai, Shanghai, China
- +2 more
Dec 1, 2022
Helicobacter Pylori Eradication Trial in Kaohsiung (Vonoprazan and Amoxicillin, Vonoprazan, Amoxicillin and Clarithromycin,
Recruiting
- Helicobacter Pylori Eradication
- Vonoprazan and Amoxicillin
- +2 more
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Jan 13, 2022
Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)
Active, not recruiting
- Triple Negative Breast Cancer
- Aldoxorubicin HCl
- +17 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
H. Pylori Infection Trial ((A) T-V14, (B) T-V7, (C) D-V14)
Not yet recruiting
- H. Pylori Infection
- (A) T-V14
- +7 more
- (no location specified)
Jan 14, 2021
Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
Recruiting
- Breast Neoplasms
- Taxanes or/and anthracycline-based therapy
-
Shengyang, Liaoning, China
- +1 more
Jan 19, 2022
Helicobacter Pylori Infection Trial in Karachi (Vonoprazan, Amoxicillin, Levofloxacin)
Recruiting
- Helicobacter Pylori Infection
- Vonoprazan, Amoxicillin, Levofloxacin
-
Karachi, Sindh, PakistanAga Khan University Hospital
Feb 5, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Triple-negative Breast Cancer Trial in Shanghai (Pyrotinib with Capecitabine, AR inhibitor combined with everolimus(B1) or
Recruiting
- Triple-negative Breast Cancer
- Pyrotinib with Capecitabine
- +6 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 8, 2022
Gastritis H Pylori Trial in Monastir (metronidazole based quadriple therapy, based quadriple therapy)
Completed
- Gastritis H Pylori
- metronidazole based quadriple therapy
- placebo based quadriple therapy
-
Monastir, TunisiaFattouma Bourguiba Hospital
Feb 23, 2021
Helicobacter Pylori Eradication Trial in Kaohsiung (esomeprazole, tripotassium dicitrate bismuthate, tetracycline and
Recruiting
- Helicobacter Pylori Eradication
- esomeprazole, tripotassium dicitrate bismuthate, tetracycline and levofloxacin
- +2 more
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Apr 28, 2023
H. Pylori Eradication in Patients With Comorbidity
Recruiting
- Helicobacter Pylori Infection
- +5 more
- The sequential therapy
- +4 more
-
Tainan, Taiwan
- +1 more
Jul 24, 2022
TNBC - Triple-Negative Breast Cancer Trial in Seoul (Talazoparib, Placebo)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- Talazoparib
- Placebo
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Feb 14, 2021
HIV Trial (Tetanus Toxoid Vaccine, Hydroxyurea, Didanosine)
Withdrawn
- HIV Infections
- Tetanus Toxoid Vaccine
- +2 more
- (no location specified)
Oct 28, 2021